Compare TNYA & ELME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TNYA | ELME |
|---|---|---|
| Founded | 2016 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 171.4M | 191.9M |
| IPO Year | 2021 | 1994 |
| Metric | TNYA | ELME |
|---|---|---|
| Price | $0.86 | $2.05 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 4 |
| Target Price | $5.33 | ★ $12.67 |
| AVG Volume (30 Days) | ★ 4.7M | 1.1M |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | N/A | ★ 707.44% |
| EPS Growth | ★ 54.96 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $206,360,000.00 |
| Revenue This Year | N/A | $5.03 |
| Revenue Next Year | N/A | $4.31 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.44 | $1.98 |
| 52 Week High | $2.35 | $17.68 |
| Indicator | TNYA | ELME |
|---|---|---|
| Relative Strength Index (RSI) | 56.82 | 46.58 |
| Support Level | $0.65 | $1.99 |
| Resistance Level | $0.94 | $2.19 |
| Average True Range (ATR) | 0.08 | 0.03 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 28.75 | 70.00 |
Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. The company's clinical-stage gene therapy candidates include TN-201 and TN-401. It operates in one operating segment, which is the business of discovering and developing potential treatments that address the underlying drivers of heart disease.
Elme Communities is a real estate investment trust engaged in owning and operating properties in the greater Washington DC metropolitan area. The company's real estate portfolio is comprised of office, retail, and multifamily properties located near transportation nodes. It derives nearly all of its income in the form of rental revenue from tenants organized into long-term leases. The company's office assets contribute the majority of this income, while the rest is split fairly evenly between its retail and multifamily locations. Elme Communities' tenants are banking, consulting, law, and financial services firms. The company operates in a single reportable segment which includes the ownership, development, redevelopment and acquisition of apartment communities.